Login / Signup

Is it worthy to treat hidradenitis suppurativa with adalimumab in patients with melanoma and other debilitating systemic diseases? A series of clinical dilemmas.

Cathy Yunjia ZhaoPablo Fernandez-Penas
Published in: The Australasian journal of dermatology (2018)
Keyphrases
  • hidradenitis suppurativa
  • rheumatoid arthritis
  • juvenile idiopathic arthritis
  • drug induced
  • ulcerative colitis